Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii

Journal of Critical Care

Volumn 40, Issue , 2017, Pages 251-256

  Jang, Ji Young ^a   Kwon, Hye Youn ^a   Choi, Eun Hee ^a   Lee, Won Yeon ^a   Shim, Hongjin ^a   Bae, Keum Seok ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Acinetobacter baumannii; Colistin; Inhalation; Nebulizer; Ventilator associated pneumonia

Indexed keywords

AMINOGLYCOSIDE; CEFOPERAZONE PLUS SULBACTAM; CLINDAMYCIN; COLISTIMETHATE; COLISTIN; CREATININE; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL INJURY; ACINETOBACTER BAUMANNII; ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FEVER; HUMAN; HYPOXEMIA; LEUKOCYTOSIS; LOADING DRUG DOSE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROBIOLOGICAL EXAMINATION; MONOTHERAPY; MULTIDRUG RESISTANCE; NEBULIZATION; NEPHROTOXICITY; OUTCOME ASSESSMENT; PERITONITIS; PNEUMONIA SEVERITY INDEX; PSEUDOMONAS PNEUMONIA; RETROSPECTIVE STUDY; SPUTUM CULTURE; SUPPURATION; SURGICAL INTENSIVE CARE UNIT; SYMPTOMATOLOGY; THORAX INJURY; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA; ACINETOBACTER INFECTION; AGED; COMPARATIVE STUDY; CRITICAL ILLNESS; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; NEBULIZER; TREATMENT OUTCOME;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; ANTI-BACTERIAL AGENTS; APACHE; COLISTIN; CRITICAL ILLNESS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85020702798     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2017.04.004     Document Type: Article

References (34)

1. Munoz-Price, L.S., Weinstein, R.A., Acinetobacter infection. N Engl J Med 358:12 (2008), 1271–1281.
2. Falagas, M.E., Koletsi, P.K., Bliziotis, I.A., The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 55:12 (2006), 1619–1629.
3. Manikal, V.M., Landman, D., Saurina, G., Oydna, E., Lal, H., Quale, J., Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 31:1 (2000), 101–106.
4. Coelho, J.M., Turton, J.F., Kaufmann, M.E., Glover, J., Woodford, N., Warner, M., et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 44:10 (2006), 3623–3627.
5. Cisneros, J.M., Rodriguez-Bano, J., Fernandez-Cuenca, F., Ribera, A., Vila, J., Pascual, A., et al. Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infec 11:11 (2005), 874–879.
6. Lee, S.O., Kim, N.J., Choi, S.H., Kim, T.H., Chung, J.W., Woo, J.H., et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Ch 48:1 (2004), 224–228.
7. Chaari, A., Mnif, B., Bahloul, M., Mahjoubi, F., Chtara, K., Turki, O., et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors. Int J Infect Dis, 17(12), 2013 E1225-E8.
8. Motaouakkil, S., Charra, B., Hachimi, A., Nejmi, H., Benslama, A., Elmdaghri, N., et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infection 53:4 (2006), 274–278.
9. Abdellatif, S., Trifi, A., Daly, F., Mahjoub, K., Nasri, R., Ben, L.S., Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial. Ann Intensive Care, 6(1), 2016, 26.
10. Kalin, G., Alp, E., Coskun, R., Demiraslan, H., Gundogan, K., Doganay, M., Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?. J Infect Chemother 18:6 (2012), 872–877.
11. Kofteridis, D.P., Alexopoulou, C., Valachis, A., Maraki, S., Dimopoulou, D., Georgopoulos, D., et al. Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator-Associated Pneumonia: A Matched Case-Control Study. Clin Infect Dis 51:11 (2010), 1238–1244.
12. Korbila, I.P., Michalopoulos, A., Rafailidis, P.I., Nikita, D., Samonis, G., Falagas, M.E., Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study. Clin Microbiol Infec 16:8 (2010), 1230–1236.
13. Lin, C.C., Liu, T.C., Kuo, C.F., Liu, C.P., Lee, C.M., Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan. J Microbiol Immunol 43:4 (2010), 323–331.
14. Michalopoulos, A., Fotakis, D., Virtzili, S., Vletsas, C., Raftopoulou, S., Mastora, Z., et al. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: A prospective study. Resp Med 102:3 (2008), 407–412.
15. Naesens, R., Vlieghe, E., Verbrugghe, W., Jorens, P., Ieven, M., A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa. Bmc Infect Dis, 11, 2011.
16. Rattanaumpawan, P., Lorsutthitham, J., Ungprasert, P., Angkasekwinai, N., Thamlikitkul, V., Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. J Antimicrob Chemoth 65:12 (2010), 2645–2649.
17. Choi, H.S., Hwang, Y.H., Park, M.J., Kang, H.M., Effects of Aerosol Colistin Treatment of Pneumonia Caused by Multi-drug Resistant Acinetobacter baumannii. Tuberculosis and Respiratory Diseases, 64(1), 2008, 7.
18. Schurink, C.A., Van Nieuwenhoven, C.A., Jacobs, J.A., Rozenberg-Arska, M., Joore, H.C., Buskens, E., et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med 30:2 (2004), 217–224.
19. Fine, M.J., Auble, T.E., Yealy, D.M., Hanusa, B.H., Weissfeld, L.A., Singer, D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. New Engl J Med 336:4 (1997), 243–250.
20. Niederman, M.S., Hospital-Acquired Pneumonia, Health Care-Associated Pneumonia, Ventilator-Associated Pneumonia, and Ventilator-Associated Tracheobronchitis: Definitions and Challenges in Trial Design. Clin Infect Dis, 51, 2010 S12-S7.
21. American Thoracic, S., Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:4 (2005), 388–416.
22. Clinical and Laboratory Standard Institute. Performance Standard for Antimicrobial Disk Susceptabulity Testing: Nineteenth Informational Supplement. CLSI 2009:M100-S17. 2009.
23. Rouby, J.J., Bouhemad, B., Monsel, A., Brisson, H., Arbelot, C., Lu, Q., et al. Aerosolized antibiotics for ventilator-associated pneumonia: lessons from experimental studies. Anesthesiology 117:6 (2012), 1364–1380.
24. Rello, J., Diaz, E., Pneumonia in the intensive care unit. Crit Care Med 31:10 (2003), 2544–2551.
25. Bassetti, M., Luyt, C.E., Nicolau, D.P., Pugin, J., Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient. Annals of Intensive Care, 6, 2016.
26. Lu, Q., Girardi, C., Zhang, M., Bouhemad, B., Louchahi, K., Petitjean, O., et al. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intens Care Med 36:7 (2010), 1147–1155.
27. Ferrari, F., Lu, Q., Girardi, C., Petitjean, O., Marquette, C.H., Wallet, F., et al. Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa. Intens Care Med 35:10 (2009), 1792–1800.
28. Doshi, N.M., Cook, C.H., Mount, K.L., Stawicki, S.P., Frazee, E.N., Personett, H.A., et al. Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study. Bmc Anesthesiol, 13, 2013.
29. Tumbarello, M., De Pascale, G., Trecarichi, E.M., De Martino, S., Bello, G., Maviglia, R., et al. Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria. Chest 144:6 (2013), 1768–1775.
30. Valachis, A., Samonis, G., Kofteridi, D.R., The Role of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia: A Systematic Review and Metaanalysis. Crit Care Med 43:3 (2015), 527–533.
31. Choi, H.K., Kim, Y.K., Kim, H.Y., Uh, Y., Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii. Yonsei Med J 55:1 (2014), 118–125.
32. Boisson, M., Gregoire, N., Couet, W., Mimoz, O., Colistin in critically ill patients. Minerva Anestesiol 79:2 (2013), 200–208.
33. Falagas, M.E., Sideri, G., Korbila, I.P., Vouloumanou, E.K., Papadatos, J.H., Kafetzis, D.A., Inhaled Colistin for the Treatment of Tracheobronchitis and Pneumonia in Critically Ill Children Without Cystic Fibrosis. Pediatr Pulm 45:11 (2010), 1135–1140.
34. Lu, Q., Luo, R.B., Bodin, L., Yang, J.X., Zahr, N., Aubry, A., et al. Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Anesthesiology 117:6 (2012), 1335–1347.